Bionoid Pharma (Bionoid Pharma) EV-to-FCF : -6.29 (As of Jun. 06, 2024)

Bionoid Pharma EV-to-FCF Chart

Bionoid Pharma Quarterly Data
	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
EV-to-FCF	Get a 7-Day Free Trial												-	-	-	-	-

Competitive Comparison of Bionoid Pharma's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Bionoid Pharma's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bionoid Pharma's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bionoid Pharma's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Bionoid Pharma's EV-to-FCF falls into.

Bionoid Pharma EV-to-FCF Calculation

Bionoid Pharma's EV-to-FCF for today is calculated as:

Bionoid Pharma's current Enterprise Value is $13.50 Mil.
Bionoid Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionoid Pharma  (OTCPK:BINP) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Bionoid Pharma's PE Ratio for today is calculated as:

Bionoid Pharma's share price for today is $0.25.
Bionoid Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-675.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Bionoid Pharma EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Bionoid Pharma's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionoid Pharma (Bionoid Pharma) Business Description